DENND4A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.056000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.623000E-01
Normal-vs-Stage2
5.418400E-02
Normal-vs-Stage3
2.296600E-01
Normal-vs-Stage4
4.562400E-01
Stage1-vs-Stage2
1.527790E-01
Stage1-vs-Stage3
4.690400E-02
Stage1-vs-Stage4
7.093800E-01
Stage2-vs-Stage3
1.974970E-01
Stage2-vs-Stage4
4.587200E-01
Stage3-vs-Stage4
4.062400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.079800E-02
Normal-vs-AfricanAmerican
6.044000E-01
Normal-vs-Asian
7.406200E-02
Caucasian-vs-AfricanAmerican
1.479040E-01
Caucasian-vs-Asian
3.456600E-01
AfricanAmerican-vs-Asian
1.458620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.189800E-02
Normal-vs-Female
8.321900E-02
Male-vs-Female
3.569000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.958400E-01
Normal-vs-Age(41-60Yrs)
1.412980E-01
Normal-vs-Age(61-80Yrs)
4.131600E-02
Normal-vs-Age(81-100Yrs)
2.847800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.894800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.847400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.326200E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.070500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.794000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.238200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.434400E-01
Normal-vs-Daily Drinker
2.590600E-01
Normal-vs-Weekly Drinker
7.009700E-02
Normal-vs-Occasional Drinker
3.806400E-01
Normal-vs-Social Drinker
2.206200E-01
Non Drinker-vs-Daily Drinker
1.280210E-01
Non Drinker-vs-Weekly Drinker
7.315600E-01
Non Drinker-vs-Occasional Drinker
6.478600E-01
Non Drinker-vs-Social Drinker
5.113000E-01
Daily Drinker-vs-Weekly Drinker
3.877600E-01
Daily Drinker-vs-Occasional Drinker
6.108300E-02
Daily Drinker-vs-Social Drinker
1.371760E-01
Weekly Drinker-vs-Occasional Drinker
5.011200E-01
Weekly Drinker-vs-Social Drinker
4.658000E-01
Occasional Drinker-vs-Social Drinker
7.917000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.377800E-01
Normal-vs-Grade 2
7.614500E-02
Normal-vs-Grade 3
5.522400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.544400E-01
Grade 1-vs-Grade 3
6.885000E-01
Grade 1-vs-Grade 4
1.377800E-01
Grade 2-vs-Grade 3
9.730400E-01
Grade 2-vs-Grade 4
7.614500E-02
Grade 3-vs-Grade 4
5.522400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.027800E-02
Normal-vs-NonDiabetic
3.361800E-01
Diabetic-vs-NonDiabetic
6.360600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.119000E-01
Normal-vs-NoPancreatitis
2.834400E-02
Pancreatitis-vs-NoPancreatitis
5.591600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.609900E-02
Normal-vs-N1
5.322000E-02
N0-vs-N1
7.235200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.500200E-01
Normal-vs-TP53-NonMutant
3.106400E-01
TP53-Mutant-vs-TP53-NonMutant
2.948100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
